Maven Securities’s OptimizeRx OPRX Stock Holding History

Maven Securities’s Portfolio OPRX Stock Details OPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-37,500	Closed	-$2.28M	–	1215
2021 Q2	$2.28M	Sell	37,500 -112,500	-75%	-$5.73M	0.09%	204
2021 Q1	$7.4M	Buy	+150,000	New	+$7.24M	0.33%	50

Other funds holding OPRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Maven Securities's OPRX Position: Q3 2021 in Review

Maven Securities sold out of OptimizeRx (OPRX) in Q3 2021, closing a stake of 37,500 shares — an estimated $2.28M sold.

Maven Securities first reported a position in OPRX in Q1 2021 and held it in 2 quarters. The position peaked at $7.4M in Q1 2021. 163 funds tracked by Wall St. Rank hold OPRX as of Q3 2021.

Maven Securities reported no remaining OptimizeRx position as of Q3 2021 after selling out during the quarter.
Maven Securities sold 37,500 OptimizeRx shares in Q3 2021, an estimated $2.28M.
Maven Securities first reported a position in OptimizeRx in Q1 2021 and held it in 2 quarters.
Maven Securities's OptimizeRx position peaked at $7.4M in Q1 2021.
163 funds tracked by Wall St. Rank held OptimizeRx as of Q3 2021.

Based on Maven Securities's 13F filing for Q3 2021, filed 15 Nov 2021.